Egret Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Egret Therapeutics General Information

Description

Developer of a clinical-stage biotechnology therapy designed to enhance recovery following serious injuries. The company offers a therapeutic approach targeting conserved injury response mechanisms to reduce secondary inflammatory damage, enabling patients with serious injuries to support recovery and reduce complications associated with inflammation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 230 Park Avenue
  • 3rd Floor
  • New York, NY 10169
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 230 Park Avenue
  • 3rd Floor
  • New York, NY 10169
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Egret Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Feb-2022 Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view Egret Therapeutics’s complete valuation and funding history, request access »

Egret Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Egret Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
FAScinate Therapeutics VC-Backed Company Minority
Turret Capital Accelerator/Incubator Minority
Johns Hopkins Technology Ventures Accelerator/Incubator
To view Egret Therapeutics’s complete investors history, request access »

Egret Therapeutics FAQs

  • When was Egret Therapeutics founded?

    Egret Therapeutics was founded in 2019.

  • Where is Egret Therapeutics headquartered?

    Egret Therapeutics is headquartered in New York, NY.

  • What is the size of Egret Therapeutics?

    Egret Therapeutics has 6 total employees.

  • What industry is Egret Therapeutics in?

    Egret Therapeutics’s primary industry is Biotechnology.

  • Is Egret Therapeutics a private or public company?

    Egret Therapeutics is a Private company.

  • What is Egret Therapeutics’s current revenue?

    The current revenue for Egret Therapeutics is .

  • Who are Egret Therapeutics’s investors?

    FAScinate Therapeutics, Turret Capital, and Johns Hopkins Technology Ventures have invested in Egret Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process